Clinical trials
Phase 2 Vomiting trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 6 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Terminated | 7 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| CinDome Pharma, Inc. | 2 |
| Indiana University | 2 |
| M.D. Anderson Cancer Center | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Ajeet Gajra | 1 |
| Albert Einstein College of Medicine | 1 |
| Alexza Pharmaceuticals, Inc. | 1 |
| Allergan | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vomiting | 56 |
| Nausea | 40 |
| Postoperative Nausea and Vomiting | 5 |
| Gastroparesis | 4 |
| Bile Duct Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Rectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.